Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Kratom Poisoning Calls Surge 1200% in the US

New CDC data show a sharp rise in kratom exposures, hospitalizations, and deaths, with multisubstance use driving the most severe outcomes.

UAE Expat MDs Stay Put as Conflict Drags On

In a country where expats dominate the medical workforce, many doctors are staying despite drone strikes, citing stability and feeling responsible for their patients.

AstraZeneca Drug Reduces Flare-ups Of Chronic Lung Disease in Late-stage Trials

AstraZeneca's experimental drug tozorakimab reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, sending its shares up as ⁠much as 3.8% on...

Spotting the Signs of Postpartum Psychosis

Postpartum psychosis can be better detected, treated, and even prevented.

Violent Parental Death Raises Mortality Risk in Kids

Parental death from violent or preventable causes may signal a need for earlier, targeted interventions to reduce downstream health risks in children.

Injectable Buprenorphine Shows Promise in Pregnancy

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Latest News

New CDC data show a sharp rise in kratom exposures, hospitalizations, and deaths, with multisubstance use driving the most severe outcomes.

In a country where expats dominate the medical workforce, many doctors are staying despite drone strikes, citing stability and feeling responsible for their patients.

AstraZeneca's experimental drug tozorakimab reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, sending its shares up as ⁠much as 3.8% on...

Postpartum psychosis can be better detected, treated, and even prevented.

Parental death from violent or preventable causes may signal a need for earlier, targeted interventions to reduce downstream health risks in children.

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

News All Time

Does 'The Pitt' Resonate With ER Docs and Hospitalists?

Show creator calls 'The Pitt' ‘a love letter.’ Do doctors agree?

Cosmetic Surgery Investigation Prompts Warnings for Patients

An investigation into cosmetic surgery chains prompts warnings from plastic surgeons and calls for transparency in how doctors are investigated.

Bloody Urine in the ED? Early Imaging May Improve Outcomes

Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying diagnosis and worsening outcomes.

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Doctors Tell MPs Corridor Care Is Driving Abuse of NHS Staff

Emergency doctors warned MPs that unsafe A&E conditions and corridor care are leaving staff exposed to rising violence.

Meningitis Risk for Young Adults With Chikungunya Vaccine

European safety committee advises product information update after review of a safety signal for aseptic meningitis following Ixchiq vaccination against chikungunya.

Is the US Entering a ‘Fifth Wave’ of the Overdose Crisis?

Experts suggest an increase in stimulant use may signal a ‘fifth wave’ of the US overdose crisis.

Opioid Risk Score Falls Short in External Study

A validation study raises concerns about an Epic risk score for opioids used in primary care.

Deprivation and Age Drive Paediatric ED Visits

Children and young individuals who frequently visit EDs over 2 years are often from the most deprived areas; infants show greater variations in reasons for ED visits than older children.

Med Students Who Don’t Match Turn to SOAP — What to Expect

Medical students going through Match will learn on March 16 whether they matched to a residency program. For those who don’t, the process of SOAP begins.

Match Brings Double Joy for Twins Who Joined Same Program

Anesthesiologists Danielle Kerr and Christine Kerr encourage medical students: ‘You will end up where you were meant to be.’

How Hospital Medicine Is Poised to Evolve This Year

Changes are coming, but this remains true: Hospitalists will be asked for more as their expertise grows.

French Probe Finds No Link Between Baby Death, Nestlé Formula

A judicial inquiry launched in France after the death ⁠of a baby has shown no link with the recalled Nestle infant ⁠formula he had consumed, the Bordeaux prosecutor said.

Work Disability Risk Can Persist Years After TBI

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

First-in-Class Tx for Dravet Syndrome Shows Early Success

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Recommended News For You

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

An Intimate Life of Medical Innovation and Charity.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

Recommended Articles For You

The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know  

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes 

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung cancer screening adherence rates decline annually after baseline screening

2.

More evidence links physical activity with improved cancer survival

3.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

4.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

5.

Taking Charge of Your Cancer Journey.

1.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

2.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

3.

Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools

4.

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells

5.

Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Navigating the Complexities of Ph Negative ALL - Part XIII

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

4.

A New Era in Managing Cancer-Associated Thrombosis

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot